London CNN —AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand.
But the vaccine has not generated revenue for AstraZeneca since April 2023, the company said.
“As multiple, variant Covid-19 vaccines have … been developed, there is a surplus of available updated vaccines.
“AstraZeneca has therefore taken the decision to initiate withdrawal of the marketing authorizations for Vaxzevria within Europe,” it added.
AstraZeneca said it would work with regulators in other countries to “align on a clear path forward,” including withdrawing marketing authorizations for the vaccine where no future commercial demand is expected.
Persons:
University of Oxford —, “, Vaxzevria, ” AstraZeneca
Organizations:
London CNN, AstraZeneca, University of Oxford, CNN, “ AstraZeneca, European Medicines Agency, Union
Locations:
United Kingdom, Vaxzevria, Europe